Skip to main content
Top
Published in: Clinical Rheumatology 10/2019

01-10-2019 | Systemic Lupus Erythematosus | Original Article

Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study

Authors: Haiyan Qu, Xuejun Hu, Jasvinder A. Singh

Published in: Clinical Rheumatology | Issue 10/2019

Login to get access

Abstract

Objective

To identify factors that might facilitate or impede the implementation of a shared decision-making in lupus electronic tool (SMILE) in clinics by assessing perspectives of clinicians, clinic champions, and patient advocacy organization leaders.

Methods

We conducted a series of semi-structured telephone interviews (25–45 minutes) about facilitators and barriers of implementing the SMILE decision-aid tool with 23 lupus care providers (18 physicians, 5 champions), and leaders of two patient advocacy organizations. Interviews were audio recorded, transcribed, coded, and analyzed.

Results

Physicians and clinic champions were from 18 geographically diverse US clinics. The patient advocacy leaders were from the Lupus Foundation of America and the Arthritis Foundation. Most of the clinics were rheumatology specialty (94%), at university-based academic centers (72%), located in urban areas (72%), had a specialized lupus clinic (72%), were very interested (72%) in the SMILE tool and were ready to implement it (89%). Several specific factors, composed as four themes, were identified that could either facilitate or impede the implementation of the SMILE tool: (1) patient-related theme: patient recruitment and education, and the clinic visit time; (2) clinic-related theme: staff work-load and time, and physical space to view and use the SMILE tool; (3) technology-related theme: Wi-Fi connection and iPad navigation; and (4) management-related theme: influence on the clinics’ daily workflow, the need of a study champion and coordination, and leadership support.

Conclusion

Physicians, staff, and patient advocacy leaders perceived the SMILE as a promising tool to facilitate patient-provider communication and quality improvement in lupus. Identification of the patient-, clinic-, technology-, and management-related barriers to the SMILE implementation will allow its integration into busy clinical practice workflow.
Key Points
• Physicians, staff and patient advocacy leaders perceived computerized lupus decision aid to be a promising tool to facilitate shared decision-making for lupus treatment.
• Stakeholder identified patient-related, clinic-resource-related, technology-related and clinic-management related themes as barriers or facilitators to viewing computerized lupus decision aid during regular clinic visits.
Appendix
Available only for authorised users
Literature
1.
go back to reference Olesińska M, Saletra A (2018) Quality of life in systemic lupus erythematosus and its measurement. Reumatologia 56:45–54CrossRef Olesińska M, Saletra A (2018) Quality of life in systemic lupus erythematosus and its measurement. Reumatologia 56:45–54CrossRef
2.
go back to reference Lai J-S, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH et al (2017) An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and neuro-QoL. Clin Rheumatol 36:555–562CrossRef Lai J-S, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH et al (2017) An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and neuro-QoL. Clin Rheumatol 36:555–562CrossRef
3.
go back to reference Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRef Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRef
4.
go back to reference Sam LS, Rana BA, HC G, Caroline G, EK A, Cristina D (2014) The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus Registry. Arthritis Rheum 66:357–368CrossRef Sam LS, Rana BA, HC G, Caroline G, EK A, Cristina D (2014) The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus Registry. Arthritis Rheum 66:357–368CrossRef
5.
go back to reference Panopalis P, Clarke AE, Yelin E (2012) The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 26:695–704CrossRef Panopalis P, Clarke AE, Yelin E (2012) The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 26:695–704CrossRef
6.
go back to reference Jolly M, Toloza S, Goker B, Clarke AE, Navarra SV, Wallace D, Weisman M, Mok CC (2018) Disease-specific quality of life in patients with lupus nephritis. Lupus 27:257–264CrossRef Jolly M, Toloza S, Goker B, Clarke AE, Navarra SV, Wallace D, Weisman M, Mok CC (2018) Disease-specific quality of life in patients with lupus nephritis. Lupus 27:257–264CrossRef
7.
go back to reference Gómez-Puerta JA, Barbhaiya M, Guan H, Feldman CH, Alarcón GS, Costenbader KH (2015) Racial/ethnic variation in all-cause mortality among United States Medicaid recipients with systemic lupus erythematosus: a Hispanic and Asian paradox. Arthritis Rheumatol 67:752–760CrossRef Gómez-Puerta JA, Barbhaiya M, Guan H, Feldman CH, Alarcón GS, Costenbader KH (2015) Racial/ethnic variation in all-cause mortality among United States Medicaid recipients with systemic lupus erythematosus: a Hispanic and Asian paradox. Arthritis Rheumatol 67:752–760CrossRef
8.
go back to reference Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 18:21CrossRef Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 18:21CrossRef
9.
go back to reference Tektonidou MG, Dasgupta A, Ward MM (2016) Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol 68:1432–1441CrossRef Tektonidou MG, Dasgupta A, Ward MM (2016) Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol 68:1432–1441CrossRef
10.
go back to reference Mehat P, Atiquzzaman M, Esdaile JM, AviNa-Zubieta A, De Vera MA (2017) Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken) 69:1706–1713CrossRef Mehat P, Atiquzzaman M, Esdaile JM, AviNa-Zubieta A, De Vera MA (2017) Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken) 69:1706–1713CrossRef
11.
go back to reference Hoover PJ, Costenbader KH (2016) Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective. Kidney Int 90:487–492CrossRef Hoover PJ, Costenbader KH (2016) Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective. Kidney Int 90:487–492CrossRef
12.
go back to reference Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D et al (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27:329–340CrossRef Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D et al (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27:329–340CrossRef
13.
go back to reference Durcan L, Clarke WA, Magder LS, Petri M (2015) Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence. J Rheumatol 42:2092–2097CrossRef Durcan L, Clarke WA, Magder LS, Petri M (2015) Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence. J Rheumatol 42:2092–2097CrossRef
14.
go back to reference Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH (2015) Medication nonadherence is associated with increased subsequent acute care utilization among medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res 67:1712–1721CrossRef Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH (2015) Medication nonadherence is associated with increased subsequent acute care utilization among medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res 67:1712–1721CrossRef
15.
go back to reference Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR (2000) Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 27:675–679PubMed Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR (2000) Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 27:675–679PubMed
16.
go back to reference Mahieu M, Yount S, Ramsey-Goldman R (2016) Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin 42:253–263CrossRef Mahieu M, Yount S, Ramsey-Goldman R (2016) Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin 42:253–263CrossRef
17.
go back to reference Haiyan Q, SR M, Graciela A, Liana F, Amye L, Maria DE et al (2016) Mapping perceptions of lupus medication decision-making facilitators: the importance of patient context. Arthritis Care Res 68:1787–1794CrossRef Haiyan Q, SR M, Graciela A, Liana F, Amye L, Maria DE et al (2016) Mapping perceptions of lupus medication decision-making facilitators: the importance of patient context. Arthritis Care Res 68:1787–1794CrossRef
18.
go back to reference Singh JA, Qu H, Yazdany J, Chatham W, Dall'era M, Shewchuk RM (2015) Barriers to medication decision making in women with lupus nephritis: a formative study using nominal group technique. J Rheumatol 42:1616–1623CrossRef Singh JA, Qu H, Yazdany J, Chatham W, Dall'era M, Shewchuk RM (2015) Barriers to medication decision making in women with lupus nephritis: a formative study using nominal group technique. J Rheumatol 42:1616–1623CrossRef
19.
go back to reference Singh JA, Qu H, Yazdany J, Chatham W, Shewchuk R (2015) Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Arthritis Res Ther 17:367CrossRef Singh JA, Qu H, Yazdany J, Chatham W, Shewchuk R (2015) Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Arthritis Res Ther 17:367CrossRef
20.
go back to reference Singh J, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG et al (2019) An individualized decision aid for diverse women with lupus nephritis (IDEA-WON): a randomized controlled trial (in press). PLoS Med 16:e1002800CrossRef Singh J, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG et al (2019) An individualized decision aid for diverse women with lupus nephritis (IDEA-WON): a randomized controlled trial (in press). PLoS Med 16:e1002800CrossRef
21.
go back to reference Singh JA, Shah N, Green C (2017) Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial. BMC Musculoskelet Disord 18:53CrossRef Singh JA, Shah N, Green C (2017) Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial. BMC Musculoskelet Disord 18:53CrossRef
24.
go back to reference Boeije H (2002) A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant 36:391–409CrossRef Boeije H (2002) A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant 36:391–409CrossRef
25.
go back to reference Dolan JG (2008) Shared decision-making – transferring research into practice: the Analytic Hierarchy Process (AHP). Patient Educ Couns 73:418–425CrossRef Dolan JG (2008) Shared decision-making – transferring research into practice: the Analytic Hierarchy Process (AHP). Patient Educ Couns 73:418–425CrossRef
26.
go back to reference Zong JY, Leese J, Klemm A, Sayre EC, Memetovic J, Esdaile JM et al (2015) Rheumatologists’ views and perceived barriers to using patient decision aids in clinical practice. Arthritis Care Res 67:1463–1470CrossRef Zong JY, Leese J, Klemm A, Sayre EC, Memetovic J, Esdaile JM et al (2015) Rheumatologists’ views and perceived barriers to using patient decision aids in clinical practice. Arthritis Care Res 67:1463–1470CrossRef
27.
go back to reference Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA (2009) The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 169:1560–1568CrossRef Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA (2009) The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 169:1560–1568CrossRef
28.
go back to reference Silvia KA, Sepucha KR (2006) Decision aids in routine practice: lessons from the breast cancer initiative. Health Expect 9:255–264CrossRef Silvia KA, Sepucha KR (2006) Decision aids in routine practice: lessons from the breast cancer initiative. Health Expect 9:255–264CrossRef
Metadata
Title
Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study
Authors
Haiyan Qu
Xuejun Hu
Jasvinder A. Singh
Publication date
01-10-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 10/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04643-w

Other articles of this Issue 10/2019

Clinical Rheumatology 10/2019 Go to the issue

Letters of Biomedical and Clinical Research

Negative specificity for DSF70 in ANA positive leprosy sera

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.